Antibiotice S.A. Logo

Antibiotice S.A.

Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.

ATB | RO

Overview

Corporate Details

ISIN(s):
ROATBIACNOR9
LEI:
315700P5G4O1L6GLMS02
Country:
Romania
Address:
VALEA LUPULUI, 707410 IAȘI

Description

Antibiotice S.A. is a pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines for human use. The company is a significant producer of anti-infective drugs, with a portfolio that includes injectable penicillins like ampicillin and nafcillin, as well as the active pharmaceutical ingredient (API) Nystatin. It operates eight GMP-certified manufacturing lines and holds US Food and Drug Administration (FDA) approval for key products, underscoring its commitment to global quality standards. The company's mission is to make valuable medicines more accessible to patients, physicians, and pharmacists by providing affordable treatments. Its product range also extends to supplements and skincare products.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 09:06
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-11-13 17:05
Raport Financiar Trimestrial - RFT
Romanian 3.8 MB
2025-11-11 15:37
Raport curent de informare a investitorilor
Romanian 1.0 MB
2025-11-07 07:37
Raport curent de informare a investitorilor
Romanian 546.9 KB
2025-11-06 12:52
Raport curent de informare a investitorilor
Romanian 643.5 KB
2025-11-06 12:49
Raport curent de informare a investitorilor
Romanian 1.0 MB
2025-11-05 10:20
Raport curent de informare a investitorilor
Romanian 291.4 KB
2025-10-03 11:39
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-10-03 11:38
Raport curent de informare a investitorilor
Romanian 1.7 MB
2025-10-01 12:53
Raport curent de informare a investitorilor
Romanian 2.4 MB
2025-09-23 08:35
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-09-17 15:12
Raport curent de informare a investitorilor
Romanian 949.8 KB
2025-09-04 12:29
Plata dividend - RC17
Romanian 2.1 MB
2025-08-13 12:27
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-08-06 12:40
Raport curent de informare a investitorilor
Romanian 137.7 KB

Automate Your Workflow. Get a real-time feed of all Antibiotice S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Antibiotice S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Antibiotice S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.